Anzeige
Mehr »
Sonntag, 28.12.2025 - Börsentäglich über 12.000 News
Breaking News: Das "Schweizer Messer" für Diabetiker ist da!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DJQ8 | ISIN: FR0014008VX5 | Ticker-Symbol: 940
Frankfurt
23.12.25 | 16:36
2,180 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
EUROAPI SAS Chart 1 Jahr
5-Tage-Chart
EUROAPI SAS 5-Tage-Chart
RealtimeGeldBriefZeit
2,1742,19627.12.
2,1742,19423.12.

Aktuelle News zur EUROAPI Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.12.Euroapi: Market update300Press Release Paris - December 16, 2025 - EUROAPI announced today that its main shareholders, Sanofi and EPIC Bpifrance, have agreed to extend further the duration of their lock-up until December...
► Artikel lesen
10.12.Euroapi: Tristan Imbert co-opted as Independent Director23
24.10.EUROAPI's Med4Cure project to strengthen pharma sovereignty13
23.10.Abolis Biotechnologies and EUROAPI Enter Into Partnership to Accelerate Pharmaceutical Innovation and Restore European Sovereignty447As part of the Important Project of Common European Interest (IPCEI) in the field of healthcare, the Med4Cure program includes public support of up to €140 million under France 2030. Abolis...
► Artikel lesen
23.10.With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of health sovereignty185Press Release The project launch event, held at the Vertolaye site, brought together State officials, elected representatives, and several project partners to accelerate pharmaceutical innovation...
► Artikel lesen
15.10.Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis20
EUROAPI Aktie jetzt für 0€ handeln
30.09.Euroapi: Change in Board's Composition221Press Release Paris - September 30, 2025 - EUROAPI today announces that, in line with best governance's practices, and following his appointment as Recipharm's Chief Financial Officer, effective...
► Artikel lesen
18.09.Science Based Targets initiative (SBTi) validates EUROAPI's near-term climate targets8
31.07.Euroapi: Availability of 2025 Half-Year Financial Report15
29.07.Euroapi: First-half 2025 results598Press Release Paris, 29th July 2025 7% to 9% 2025 Core EBITDA margin guidance reaffirmed, with ambition to be in the upper part of the range, supported by thorough execution of the FOCUS-27 plan,...
► Artikel lesen
01.07.EuroAPI sheds UK facility as restructuring plan rolls on28
30.06.Particle Dynamics Acquires EUROAPI UK16
30.06.EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan740 Press Release Paris - June 30, 2025 - EUROAPI today announced the signing of a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, the subsidiary operating its Haverhill manufacturing...
► Artikel lesen
04.06.Frédéric Robert appointed EUROAPI's Chief Commercial Officer overseeing API Solutions and CDMO activities330Paris - June 4, 2025 - EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce...
► Artikel lesen
03.03.Euroapi: Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline835Press Release Paris, 3rd March, 2025 Full-year 2024 results1: Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,12